Navigation Links
Cotara in Medical News

Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009

... At the same time, we advanced our bavituximab and cotara clinical trials in FY 2009 while keeping R&D c...ology platform." Mr. King continued, "Our cotara clinical program continues to advance with patient...icine 2009 Annual Meeting, further confirming that cotara specifically localizes to brain tumors at high con...

Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program

...Phase I and Phase II Clinical Trials Have Received cotara to Date, with a Good Safety Profile and Longer-Ter...patient enrollment in the final cohort of a second cotara GBM trial, a dose confirmation and dosimetry study... than 65 patients with recurrent GBM have received cotara in the current and previous clinical studies. Loc...

Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials

...fficacy trial. In patients treated in the studies, cotara appears to be safe and well tolerated, with no dos..."We are encouraged by early results from these two cotara clinical studies and look forward to presenting da...s in this trial receive an initial imaging dose of cotara before receiving the therapeutic dose. The study's...

Peregrine Pharmaceuticals Initiates Patient Enrollment In New Cotara(R) Brain Cancer Trial

...dly form of brain cancer. In pilot studies cotara has shown encouraging results, demonstrating a 58%...ma trials would provide a foundation for advancing cotara into Phase III trials. "Cotara has demonst...ry and dosing data being collected in ongoing U.S. cotara trials, will help us determine the optimal design ...
Cotara in Medical Technology

Data To Be Presented at ASCO Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer

...s with minimal radiation exposure to other organs. cotara is a targeted monoclonal antibody linked to a radi...a multiforme (GBM), a deadly form of brain cancer. cotara specifically targets cells at the center of brain ...study, confirming other clinical data showing that cotara appears to have a good safety profile. The...

Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India

...aging signs of anti-tumor activity seen in earlier cotara brain cancer studies," said Steven W. King, presid...ective is to confirm the maximum tolerated dose of cotara in these GBM patients. Secondary objectives includ...ts in the trial are receiving a single infusion of cotara by convection-enhanced delivery (CED), an NIH-deve...
Cotara in Biological Technology

Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine

...se, and it can produce large quantities of labeled drug product rapidly, reliably and cost-effectively. We have been using the new process to produce cotara for our ongoing brain cancer trials and can report that it works as well in clinical practice as it does in the lab. We believe it is significant tha...

Data Presented at Society of Nuclear Medicine 2009 Annual Meeting Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer

... with minimal radiation exposure to other organs. cotara is a targeted monoclonal antibody linked to a radi...rst two cohorts of the study, the concentration of cotara in brain tumors was on average more than 300-fold ...al time of six months for recurrent GBM patients. cotara is currently being tested in this Phase I dose res...

Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009

...rior bavituximab cancer study and from our ongoing cotara study in glioblastoma (GBM) patients at the presti...(R) Brain Cancer Program: Peregrine advanced the cotara brain cancer program during the quarter. -- Presented data from the cotara dosing and dosimetry study at the ASCO 2008 Annual...

Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008

...tudy in HCV patients co-infected with HIV, and two cotara studies for the treatment of glioblastoma multifor...we strengthened the foundation for progress in the cotara clinical program by initiating additional sites in two ongoing trials of cotara in patients with GBM. Data was presented at the 20...

Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study

... in brain tumors, leaving healthy tissue in the body largely unaffected. The release also reported that all of the GBM patients treated to date in the cotara Phase II safety and efficacy trial have survived past the expected median survival time for relapsed GBM patients, an early but encouraging result. Th...

Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008

... distinguished brain cancer center and experienced cotara clinical study site -- the Barrow Neurological Ins...tiative to raise awareness for the bavituximab and cotara programs in the scientific and medical communities...ek of an abstract discussing patient data from the cotara dosimetry trial for presentation at the 2008 ASCO ...

Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008

...nd demonstrated encouraging signs of anti-viral activity. Cotara(R) Brain Cancer Clinical Program To help accelerate the ongoing Phase II trial of cotara in patients with glioblastoma multiforme, one of the most deadly forms of brain cancer, Peregrine recently added two new sites to the study, for a tot...
Other Tags
(Date:7/26/2014)... “BRIC Sinuscopes Market Outlook to 2020,? provides key market ... value, in millions of US dollars, volume (in units) ... – Rigid Non-Video Sinuscopes. , The report also provides ... these market categories, and global corporate-level profiles of the ... related to the Sinuscopes market wherever available. , Overview ...
(Date:7/26/2014)... 26, 2014 Multiple sclerosis (MS), ... is an inflammatory disease in which the insulating ... spinal cord are damaged. This damage disrupts the ... communicate, resulting in a wide range of signs ... problems. Multiple sclerosis takes several forms, with new ...
(Date:7/26/2014)... Wa (PRWEB) July 26, 2014 According ... by Vkool.com, this is a comprehensive bodybuilding program that ... without using anabolic steroids . The program also ... muscle without cardio. , Vkool reveals in its ... and workouts that can help men get ripped and ...
(Date:7/25/2014)... 26, 2014 Dental Perfection, a Derby ... services including general dentistry, clear braces and much more, ... this year in Derby. The new practice, which is ... Medical Centre in Littleover, Derby. Patients may already pre-register ... The new dental practice, which is headed by Invisalign ...
(Date:7/25/2014)... 26, 2014 According to a ... by Product (vibration monitoring, thermography, ultrasound emission, lubricating ... Component, Application and Geography - Global Forecast to ... health monitoring market is expected to reach $2.50 ... 2020. , Browse 117 market data Tables and ...
Breaking Medicine News(10 mins):Health News:Sinuscopes Market in BRIC (Brazil, Russia, India & China) Forecast to 2020 Report Available at MarketOptimizer.org 2Health News:Sinuscopes Market in BRIC (Brazil, Russia, India & China) Forecast to 2020 Report Available at MarketOptimizer.org 3Health News:Sinuscopes Market in BRIC (Brazil, Russia, India & China) Forecast to 2020 Report Available at MarketOptimizer.org 4Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 3Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 4Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 2Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 3Health News:Derby Cosmetic Dentist Dental Perfection to Open New Practice in Littleover, Derby this September 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 4
(Date:7/24/2014)... 24, 2014) Scientists at The New York ... step closer to creating a viable cell replacement ... cells. , For the first time, NYSCF ... from skin samples of patients with primary progressive ... protocol to induce these stem cells into becoming ...
(Date:7/24/2014)... two factors that characterize sustainable university and college ... qualified physics teachers. Specifically, one or more faculty ... in combination with institutional motivation and commitment can ... Engineering and Math (STEM) teacher shortages are especially ... way for institutions seeking to increase the number ...
(Date:7/24/2014)... own microbial terroir, meaning the microbial populations found on ... product, creating the final flavor according to research published ... Environmental Microbiology . This is the first time investigators ... , Many sake makers inoculate with both bacteria ... the University of California, Davis, but he and his ...
Breaking Biology News(10 mins):NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Creating sustainable STEM teacher preparation programs 2The microbes make the sake brewery 2
Other Contents